Form 4: MeridianLink Executive Chris Maloof Executes Stock Options and Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Chris Maloof, President, Go To Market at MeridianLink, Inc., exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • Chris Maloof, President, Go To Market at MeridianLink, Inc., executed transactions involving the company's common stock.
  • On June 17, 2024, Maloof exercised options to acquire 43,317 shares at $6.0606 per share and sold the same amount at a weighted average price of $20.3072.
  • On June 18, 2024, Maloof exercised options to acquire 35,433 shares at $6.0606 per share and sold 46,296 shares at a weighted average price of $20.2964.
  • On June 20, 2024, Maloof sold 14,320 shares at a weighted average price of $20.4798.
  • These transactions were executed under a Rule 10b5-1 trading plan adopted on March 18, 2024.
  • Following these transactions, Maloof directly owns 344,695 shares of MeridianLink common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment.

Industry Context

Executive stock transactions are common and closely monitored, especially in the context of pre-arranged trading plans. These plans allow insiders to sell shares without being accused of trading on non-public information.

Comparison to Industry Standards

  • Executive compensation packages often include stock options to align management's interests with those of shareholders.
  • Rule 10b5-1 trading plans are a standard practice for corporate insiders to manage their stock holdings while avoiding accusations of insider trading.
  • The weighted average sale prices are within a normal range for market fluctuations.

Stakeholder Impact

  • Shareholders may be interested in executive stock transactions as an indicator of management's confidence in the company.
  • The transactions themselves are unlikely to have a significant impact on other stakeholders.

Key Dates

DateDescription
March 18, 2024Date the Reporting Person adopted the Rule 10b5-1 trading plan
April 30, 2024Date of common stock acquisition under the Employee Stock Purchase Plan
June 17, 2024Date of stock option exercise and sale of shares
June 18, 2024Date of stock option exercise and sale of shares
June 20, 2024Date of sale of shares
October 15, 2029Expiration date of the stock options

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.